Annual Report 2006-2007 of Sun Pharmaceutical Industries Limited

It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2006-2007. During the financial year, The Company’s Total Income Rs. 24,040 million. Net Profit after Tax for the year Rs. 6,289 million. Preference Share Rs. 1/-. Equity shares final Rs. 1300. Book value per equity share (Rs. 5 paid up) Rs. 126/-. During the year under review, The Company received notices from Foreign Currency Convertible Bond (FCCB) holders for exercising the conversion option in respect of 124,286 FCCBs of US $ 1000 each out of 350,000 FCCBs. Accordingly, the Company allotted during the year ended 31^st March 2007, 7,670,483 equity shares of Rs. 5/- each of these Bondholders at the conversion price of Rs. 729.30 per share.

The Board of Directors is pleased to recommend an interim preference share dividend of @6% p.a. (previous year 6% p.a.) on paid-up amount of outstanding preference shares and an interim equity share dividend of @135% p.a. (previous year 110% p.a.) for the year ended 31^st March 2007.

More Annual Report of Sun Pharmaceutical Industries Limited: